MicroRNA Expression Characterizes Oligometastasis(es)
Creators
- Lussier, Yves A.1
- Xing, H. Rosie1
- Salama, Joseph K.2
- Khodarev, Nikolai N.1
- Huang, Yong1
- University of Chicago1
- Khan, Sajid A.1
- Yang, Xinan1
- Hasselle, Michael D.1
- Darga, Thomas E.1
- Malik, Renuka1
- Fan, Hanli1
- Perakis, Samantha1
- Filippo, Matthew1
- Corbin, Kimberly1
- Lee, Younghee1
- Posner, Mitchell C.1
- Chmura, Steven J.1
- 1. University of Chicago
- 2. Duke University Medical Center
Description
Background: Cancer staging and treatment presumes a division into localized or metastatic disease. We proposed an intermediate state defined by ≤5 cumulative metastasis(es), termed oligometastases. In contrast to widespread polymetastases, oligometastatic patients may benefit from metastasis-directed local treatments. However, many patients who initially present with oligometastases progress to polymetastases. Predictors of progression could improve patient selection for metastasis-directed therapy.
Methods: Here, we identified patterns of microRNA expression of tumor samples from oligometastatic patients treated with high-dose radiotherapy.
Results: Patients who failed to develop polymetastases are characterized by unique prioritized features of a microRNA classifier that includes the microRNA-200 family. We created an oligometastatic-polymetastatic xenograft model in which the patient-derived microRNAs discriminated between the two metastatic outcomes. MicroRNA-200c enhancement in an oligometastatic cell line resulted in polymetastatic progression.
Conclusions: These results demonstrate a biological basis for oligometastases and a potential for using microRNA expression to identify patients most likely to remain oligometastatic after metastasis-directed treatment.
Files
journal.pone.0028650.pdf
Files
(5.5 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:eeb2d4addd62dc10f3613286a307b3f1 |
3.9 MB | Preview Download |
|
md5:db4da254f585b4ce000d363c650ac13a
|
1.6 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pone.0028650
- Other
- oai:uchicago.tind.io:10478
Funding
- Ludwig Center for Metastasis Research
- Center for Radiation Therapy
- Chicago Tumor Institute
- Dr. Lloyd Old
- Mr. and Mrs. Vincent Foglia
- Foglia foundation
- Lung Cancer Research Foundation
- Cancer Research Foundation
- National Institutes of Health
- K22 LM008308-04
- National Institutes of Health
- 5UL1RR024999-04
- University of Chicago
- Comprehensive Cancer Center
- National Center for the Multi Scale Analysis of Genomic and Cellular Networks
- 5U54CA121852-5